Mild Cognitive Impairment (MCI) clinical trials
Showing 101–150 of 228 active trials. Describe your situation to see which ones look like a fit.
- Predicting Pre-dementia
- A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
- Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- MCI Speech in Noise
- Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- Vanderbilt Memory and Aging Project
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Moving Yourself in Space and Time: MYSTIC
- Crownlands Observing Progression With Neurons Study
- Automated IADL Sensing to Refine Measurement of Older Adult Daily Activity
- Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
- ADRC Clinical Cohort (Alzheimer's Disease)
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Study to Understand Novel Biomarkers in Researching Dementia
- Tennessee Alzheimer's Project
- Genetic Studies of Early-onset Dementia
- Autoimmune Features of Neurodegenerative Disorders
- OCT Angiography and NRAI in Dementia
- Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
- Wake Forest Alzheimer's Disease Clinical Core
- F 18 T807 Tau PET Imaging of Alzheimer's Disease
- Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
- Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
- Longitudinal Cognitive Assessment by BoCA
- DC Longitudinal Study on Aging and Specimen Bank
- Retinal Imaging in Neurodegenerative Disease
- Novel Glaucoma Diagnostics
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- Stimulating the Aging Brain Using Brain and Sensory Stimulation
- e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most
- Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment
- δ in Dementia Clinical Trials
- bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
- Senicapoc in Alzheimer's Disease
- Working Memory Training in Patients with Mild Cognitive Impairment
- Remote Sensing for ADRD-Specific Activities Identification in Older Adults
- Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
- A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients
- Time Restricted Eating in Alzheimer's Disease
- Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia
- Wayfinding Intervention and Long-Term Memory
- Neuromodulation of Memory in Aging
- Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment
- The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
- GAMES Intervention in MCI (Mild Cognitive Impairment)
- TabCAT Brain Health Assessment in Primary Care
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.